移植診断薬の世界市場レポート 2025年

移植診断薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.4％で27億5,000万米ドルに成長します。予測期間の成長は、患者中心のアプローチ、規制の適応、生体ドナー移植の増加、個別化移植医療、移植手術の成長に起因します。予測期間の主な動向には、教育・啓発プログラム、市場拡大戦略、規制ガイドラインの進化、免疫抑制療法の最適化、バイオマーカー開発などがあります。

慢性疾患の増加は、今後数年間の移植診断薬市場の成長を牽引すると予測されます。慢性疾患は、糖尿病、心臓病、喘息、関節炎などの病気を含む、継続的な管理と治療を必要とする長期的な病状です。慢性疾患の増加は、人口の高齢化、不健康なライフスタイル（食生活の乱れ、運動不足、喫煙など）の増加、環境汚染物質への曝露の増加などの要因に起因しています。移植診断薬は、臓器の機能、適合性、移植の潜在的な必要性を評価するために不可欠です。例えば、米国を拠点とする健康団体である米国がん協会が発表した調査によると、2022年には米国で60万9,360人のがん死亡者と190万人の新規がん症例が発生し、毎日約1,670人が死亡すると予測されています。したがって、慢性疾患の蔓延が移植診断薬市場拡大の主要因となっています。

臓器移植件数の増加は、移植診断薬市場の成長に大きく貢献すると予想されます。臓器移植は、ある人（ドナー）から臓器、組織、または細胞群を取り出し、別の人（レシピエント）に移植する、または同じ個人内に移植する外科手術です。移植診断薬は臓器移植に不可欠であり、患者の転帰の改善や適合性評価の向上など、多くの利点を提供します。これらの診断は、移植前のドナー適格性スクリーニング、移植後の合併症の特定、抗菌剤の有効性のモニタリングなどに利用されています。例えば、英国の政府機関であるNHS Blood and Transplant（NHSBT）が2023年7月に発表した報告書によると、2022/23年の間に臓器移植を受ける患者数は5％増加し、心臓の提供だけでも20％増加するといいます。これは、2,386人のドナーからの合計4,532件の移植に相当します。したがって、臓器移植件数の増加が移植診断薬市場の成長促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界移植診断薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の移植診断薬市場：成長率分析
• 世界の移植診断薬市場の実績：規模と成長, 2019-2024
• 世界の移植診断薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界移植診断薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の移植診断薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 試薬および消耗品
• 機器
• ソフトウェアとサービス
• 世界の移植診断薬市場移植の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 固形オルガン
• 幹細胞
• 世界の移植診断薬市場オルガン別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腎臓
• 肝臓
• 心臓
• 肺
• 膵臓
• 世界の移植診断薬市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非分子アッセイ
• 分子アッセイ
• 世界の移植診断薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と移植センター
• 調査室と移植センター
• 商用サービスプロバイダー
• 世界の移植診断薬市場試薬および消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• PCR試薬
• 抗体と抗原
• サンプル採取キット
• 制御材料
• 世界の移植診断薬市場、楽器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フローサイトメーター
• PCRマシン
• シーケンサー
• ルミノメーター
• 世界の移植診断薬市場ソフトウェアとサービスのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• データ分析ソフトウェア
• 検査情報管理システム（LIMS）
• コンサルティングサービス
• 技術サポートおよびメンテナンスサービス

第7章 地域別・国別分析

• 世界の移植診断薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の移植診断薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 移植診断薬市場：競合情勢
• 移植診断薬市場：企業プロファイル
  • F. Hoffmann La-Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Becton-Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Illumina Inc.
• BioMerieus S.A
• Biomerieux SA
• Grafton Companies
• Bio-rad Laboratories Inc.
• Sigma-Aldrich Corporation
• Qiagen N.V.
• Immucor Transplant Diagnostics Inc.
• Immucor Inc.
• Luminex Corporation
• Affymetrix Inc.
• CareDx Company
• One Lambda Inc.
• Eurobio Scientific Group
• Gendx BV

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 移植診断薬市場2029：新たな機会を提供する国
• 移植診断薬市場2029：新たな機会を提供するセグメント
• 移植診断薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Transplant diagnostics encompass tests performed prior to the transplantation of a donor organ to the recipient patient. In the context of organ transplantation and hematopoietic stem cell transplantation, transplantation diagnostics primarily focus on histocompatibility and immunogenetics.

The primary categories within the transplant diagnostics market include reagents and consumables, instruments, and software and services. Transplant diagnostics instruments are specifically designed products aimed at enhancing the speed and quality of transplant diagnostics. Employing non-molecular assay and molecular assay technologies, transplant diagnostics cover various organs such as kidneys, liver, heart, lungs, and pancreas. The transplant types involved are solid organ and stem cells, with end-users including hospitals and transplant centers, research laboratories and transplant centers, as well as commercial service providers.

The transplant diagnostics market research report is one of a series of new reports from The Business Research Company that provides transplant diagnostics market statistics, including transplant diagnostics industry global market size, regional shares, competitors with a transplant diagnostics market share, detailed transplant diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the transplant diagnostics industry. This transplant diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transplant diagnostics market size has grown steadily in recent years. It will grow from $2.01 billion in 2024 to $2.07 billion in 2025 at a compound annual growth rate (CAGR) of 3.0%. The growth in the historic period can be attributed to development of hla typing, growth in organ transplantations, immunosuppressive therapy advancements, introduction of cross-matching techniques, regulatory standardization.

The transplant diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.75 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to patient-centric approaches, regulatory adaptations, rise in living donor transplants, personalized transplant medicine, growth in transplant procedures. Major trends in the forecast period include education and awareness programs, market expansion strategies, regulatory guidelines evolution, immunosuppressive therapy optimization, biomarker development.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the transplant diagnostics market in the coming years. Chronic diseases are long-term medical conditions that require ongoing management and treatment, including illnesses such as diabetes, heart disease, asthma, and arthritis. The rise in chronic diseases can be attributed to factors such as an aging population, a higher incidence of unhealthy lifestyles (including poor diet, physical inactivity, and smoking), and increased exposure to environmental pollutants. Transplant diagnostics are essential for assessing organ function, compatibility, and the potential need for transplantation due to the long-term damage these conditions can inflict on vital organs. For instance, research published by the American Cancer Society, a U.S.-based health organization, projected that in 2022, there would be 609,360 cancer deaths and 1.9 million new cancer cases in the U.S., translating to approximately 1,670 fatalities each day. Therefore, the growing prevalence of chronic diseases is a key driver of the transplant diagnostics market's expansion.

The rising number of organ transplants is expected to significantly contribute to the growth of the transplant diagnostics market. Organ transplantation is a surgical procedure that involves removing an organ, tissue, or group of cells from one person (the donor) and transplanting it into another person (the recipient), or relocating it within the same individual. Transplant diagnostics are vital in organ transplantation, offering numerous benefits such as improved patient outcomes and better compatibility assessment. These diagnostics are utilized for pre-transplant donor eligibility screening, identifying post-transplant complications, and monitoring the effectiveness of antimicrobial agents. For example, a report published in July 2023 by NHS Blood and Transplant (NHSBT), a UK-based government agency, indicated a 5% increase in the number of patients receiving organ transplants during the 2022/23 period, with heart donations alone rising by 20%. This amounted to a total of 4,532 transplants from 2,386 donors. Therefore, the increasing number of organ transplants is a key driver of growth in the transplant diagnostics market.

Prominent companies in the transplant diagnostics market are strategically introducing advanced services to enhance their market profitability. Advanced transplant diagnostic services entail the utilization of innovative diagnostic tools and technologies to enhance the precision and efficiency of pre-transplant and post-transplant testing procedures. For example, in March 2023, Quest Diagnostics, a US-based medical laboratory company, unveiled Quest Advanced Specialized Transplant Services, an extensive array of cutting-edge diagnostics and support services designed to enhance access to laboratory tests for solid organ, human cell, and tissue transplants. This comprehensive offering includes over 170 specialized transplant and infectious disease tests, longitudinal trend analysis of test results integrated into the physician's electronic medical record (EMR), and 24/7 support services, including medical consultation to ensure appropriate test selection and result interpretation impacting patient care. The new services expand upon Quest's previous transplant testing offerings with added capabilities, including patient-customized information packets and expedited testing for patients visiting Quest's 2,100 patient service centers, with some test results obtainable within 8-24 hours.

Companies are increasingly adopting Next Generation Sequencing (NGS) for donor-recipient matching tests. NGS technology facilitates the sequencing of an entire human genome, enabling the matching of genes between donors and recipients to determine the suitability for organ transplantation. Virtually all current transplant diagnostic tests and devices leverage NGS technology to inform decisions related to organ transplantation. Castle Biosciences, for instance, introduced the Decision Dx-CMSeq Test, utilizing NGS (Next Generation Sequencing) to identify somatic mutations in genes.

In August 2022, Eurobio Scientific, a biotechnology company based in France, completed the acquisition of GenDx for $134.3 million (€135 million). This strategic move is anticipated to bolster Eurobio's research efforts in the field of transplantation. GenDx is a molecular diagnostics startup headquartered in the Netherlands.

Major companies operating in the transplant diagnostics market include F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomerieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc

North America was the largest region in the transplant diagnostics market in 2024. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The transplant diagnostics market includes revenues earned by entities by PCR-based molecular assays, sequencing-based molecular assays, and non-molecular assay technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transplant Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transplant diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transplant diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transplant diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Reagent And Consumables; Instrument; Software And Services
• 2) By Transplant Type: Solid Organ; Stem Cell
• 3) By Organ: Kidney; Liver; Heart; Lung; Pancreas
• 4) By Technology: Non Molecular Assay; Molecular Assay
• 5) By End User: Hospitals And Transplant Centers; Research Laboratories AndTransplant Centers; Commercial Service Providers
• Subsegments:
• 1) By Reagent And Consumables: PCR Reagents; Antibodies And Antigens; Sample Collection Kits; Control Materials
• 2) By Instrument: Flow Cytometers; PCR Machines; Sequencers; Luminometers
• 3) By Software And Services: Data Analysis Software; Laboratory Information Management Systems (LIMS); Consulting Services; Technical Support And Maintenance Services
• Companies Mentioned: F. Hoffmann La-Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Becton-Dickinson and Company; Hologic Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transplant Diagnostics Market Characteristics

3. Transplant Diagnostics Market Trends And Strategies

4. Transplant Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Transplant Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Transplant Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Transplant Diagnostics Market Growth Rate Analysis
• 5.4. Global Transplant Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Transplant Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Transplant Diagnostics Total Addressable Market (TAM)

6. Transplant Diagnostics Market Segmentation

• 6.1. Global Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagent And Consumables
• Instrument
• Software And Services
• 6.2. Global Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solid Organ
• Stem Cell
• 6.3. Global Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kidney
• Liver
• Heart
• Lung
• Pancreas
• 6.4. Global Transplant Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non Molecular Assay
• Molecular Assay
• 6.5. Global Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Transplant Centers
• Research Laboratories And Transplant Centers
• Commercial Service Providers
• 6.6. Global Transplant Diagnostics Market, Sub-Segmentation Of Reagent And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Reagents
• Antibodies And Antigens
• Sample Collection Kits
• Control Materials
• 6.7. Global Transplant Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flow Cytometers
• PCR Machines
• Sequencers
• Luminometers
• 6.8. Global Transplant Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis Software
• Laboratory Information Management Systems (LIMS)
• Consulting Services
• Technical Support And Maintenance Services

7. Transplant Diagnostics Market Regional And Country Analysis

• 7.1. Global Transplant Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Transplant Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transplant Diagnostics Market

• 8.1. Asia-Pacific Transplant Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transplant Diagnostics Market

• 9.1. China Transplant Diagnostics Market Overview
• 9.2. China Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transplant Diagnostics Market

• 10.1. India Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transplant Diagnostics Market

• 11.1. Japan Transplant Diagnostics Market Overview
• 11.2. Japan Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transplant Diagnostics Market

• 12.1. Australia Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transplant Diagnostics Market

• 13.1. Indonesia Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transplant Diagnostics Market

• 14.1. South Korea Transplant Diagnostics Market Overview
• 14.2. South Korea Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transplant Diagnostics Market

• 15.1. Western Europe Transplant Diagnostics Market Overview
• 15.2. Western Europe Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transplant Diagnostics Market

• 16.1. UK Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transplant Diagnostics Market

• 17.1. Germany Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transplant Diagnostics Market

• 18.1. France Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transplant Diagnostics Market

• 19.1. Italy Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transplant Diagnostics Market

• 20.1. Spain Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transplant Diagnostics Market

• 21.1. Eastern Europe Transplant Diagnostics Market Overview
• 21.2. Eastern Europe Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transplant Diagnostics Market

• 22.1. Russia Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transplant Diagnostics Market

• 23.1. North America Transplant Diagnostics Market Overview
• 23.2. North America Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transplant Diagnostics Market

• 24.1. USA Transplant Diagnostics Market Overview
• 24.2. USA Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transplant Diagnostics Market

• 25.1. Canada Transplant Diagnostics Market Overview
• 25.2. Canada Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transplant Diagnostics Market

• 26.1. South America Transplant Diagnostics Market Overview
• 26.2. South America Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transplant Diagnostics Market

• 27.1. Brazil Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transplant Diagnostics Market

• 28.1. Middle East Transplant Diagnostics Market Overview
• 28.2. Middle East Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transplant Diagnostics Market

• 29.1. Africa Transplant Diagnostics Market Overview
• 29.2. Africa Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transplant Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Transplant Diagnostics Market Competitive Landscape
• 30.2. Transplant Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann La-Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton-Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Transplant Diagnostics Market Other Major And Innovative Companies

• 31.1. Illumina Inc.
• 31.2. BioMerieus S.A
• 31.3. Biomerieux SA
• 31.4. Grafton Companies
• 31.5. Bio-rad Laboratories Inc.
• 31.6. Sigma-Aldrich Corporation
• 31.7. Qiagen N.V.
• 31.8. Immucor Transplant Diagnostics Inc.
• 31.9. Immucor Inc.
• 31.10. Luminex Corporation
• 31.11. Affymetrix Inc.
• 31.12. CareDx Company
• 31.13. One Lambda Inc.
• 31.14. Eurobio Scientific Group
• 31.15. Gendx BV

32. Global Transplant Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transplant Diagnostics Market

34. Recent Developments In The Transplant Diagnostics Market

35. Transplant Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Transplant Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Transplant Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Transplant Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer